Health & Fitness
Health and Fitness
Health and Fitness
Wed, May 2, 2012Tue, May 1, 2012Mon, April 30, 2012Sun, April 29, 2012Sat, April 28, 2012Fri, April 27, 2012Thu, April 26, 2012Wed, April 25, 2012Tue, April 24, 2012Mon, April 23, 2012Sun, April 22, 2012Sat, April 21, 2012Fri, April 20, 2012Thu, April 19, 2012Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
Published in Health and Fitness on Wednesday, April 25th 2012 at 13:46 GMT by Market Wire
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012... -- SAN DIEGO, April 25, 2012 /PRNewswire/ --
Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
CONFERENCE CALL AND WEBCAST SCHEDULED FOR WEDNESDAY, MAY 2, 2012
SAN DIEGO, April 25, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: [ NBIX ]) announced today that the Company will report its first quarter 2012 financial results after the Nasdaq market closes on Wednesday, May 2, 2012. Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Wednesday afternoon, May 2, 2012 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
Participants can access the live conference call by dialing 800-894-5910, (US) or 785-424-1052 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at [ http://www.neurocrine.com ]
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 800-753-8878 (US) or 402-220-0688 (International) using the conference ID: NBIX. The call will be archived for two weeks.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine-related diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at [ http://www.neurocrine.com ].
SOURCE Neurocrine Biosciences, Inc.
[ Back to top ] RELATED LINKS
[ http://www.neurocrine.com ]
